Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine plus haloperidol versus fentanyl for acute pain in the emergency department
IRCT20200608047684N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine, haloperidol and fentanyl in acute pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain relief by VNRS and Adverse effects. Started Jul 2020; status: completed.
02
Drugs
ketaminehaloperidolfentanyl
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20200608047684N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200608047684N1.